Achieving Value in Cancer Care
This video explores the value proposition in cancer care, with practical considerations for reducing costs at both the hospital and physician level while maintaining optimal care for cancer patients.
With the rising costs of targeted agents, immunotherapies, and combination treatment strategies, creating value while maintaining optimal care for cancer patients is of critical importance.
In this video, Daniel R. Gomez, MD, of MD Anderson Cancer Center, discusses the value proposition in cancer care, with practical considerations for reducing costs at both the hospital and physician level without sacrificing high levels of care to patients.
Gomez gave a presentation on this topic at the 2017 Multidisciplinary Thoracic Cancers Symposium, held March 16–18 in San Francisco.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
![“These results and the lack of systemic toxicity observed with [TTFields] provide patients with a promising new treatment option,” according to Joachim Aerts, MD, an investigator of the phase 3 LUNAR trial (NCT02973789).](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2F7d7dfad7849391f4be3ebd2cf39c24f5369cfcd1-1200x1176.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "“These results and the lack of systemic toxicity observed with [TTFields] provide patients with a promising new treatment option,” according to Joachim Aerts, MD, an investigator of the phase 3 LUNAR trial (NCT02973789).")
